Bank Of New York Mellon Corp Point Biopharma Global Inc. Transaction History

Bank Of New York Mellon Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$5.72 - $9.78 $1.46 Million - $2.5 Million	255,729 New	255,729 $1.86 Million
Q3 2022 Nov 14, 2022	BUY	$7.24 - $10.31 $153,191 - $218,149	21,159 Added 10.35%	225,653 $1.74 Million
Q2 2022 Aug 15, 2022	BUY	$5.6 - $9.5 $983,712 - $1.67 Million	175,663 Added 609.29%	204,494 $1.39 Million
Q3 2021 Nov 12, 2021	BUY	$7.42 - $11.26 $213,926 - $324,637	28,831 New	28,831 $222,000

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.